Effect of thiol antioxidant on body fat and insulin reactivity

Journal of Molecular Medicine

Volumn 82, Issue 5, 2004, Pages 336-344

  Hildebrandt, Wulf ^a,d   Hamann, Andreas ^b   Krakowski Roosen, Holger ^a   Kinscherf, Ralf ^c   Dugi, Klaus ^b   Sauer, Roland ^a   Lacher, Sabrina ^a   Nöbel, Nuria ^a   Bodens, Anne ^b   Bellou, Vassiliki ^b   Edler, Lutz ^a   Nawroth, Peter ^b   Dröge, Wulf ^a,c,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Body fat; Hyperlipidemia; Insulin reactivity; Obesity; Thiol antioxidant treatment

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CREATININE; CYSTEINE; FAT; GLUCOSE; INSULIN; INSULIN RECEPTOR KINASE; THIOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BODY FAT; BRAIN METABOLISM; CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; SMOKING;

ACETYLCYSTEINE; ADIPOSE TISSUE; ADULT; ANTIOXIDANTS; BODY WEIGHT; CELL LINE; CREATINE; CYSTEINE; CYSTINE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERLIPIDEMIAS; INSULIN; MALE; MIDDLE AGED; OBESITY; RECEPTOR, INSULIN; SULFHYDRYL COMPOUNDS;

EID: 2542505624     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0532-5     Document Type: Article

References (42)

1. May JM, DeHäen C (1979) Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cell. J Biol Chem 254:2214-2220
2. Mukherjee SP, Attaway EJ, Mukerjee C (1982) Insulin-like stimulation by hydrogen peroxide production in adipocytes by insulin receptor antibodies. Biochem Int 4:305
3. i2. J Biol Chem 272:10135-10143
4. Hayes GR, Lockwood DH (1987) Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc Natl Acad Sci USA 84:8115-8119
5. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265:2896-2902
6. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N (1998) Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47:1562-1569
7. 2 in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem 274:25078-25084
8. Blair AS, Hajduch E, Litherland GJ, Hundal HS (1999) Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J Biol Chem 274:36293-36299
9. Kietzmann T, Fandrey J, Acker H (2000) Oxygen radicals as messengers in oxygen-dependent gene expression. News Physiol Sci 15:202-208
10. Tirosh A, Rudich A, Potashnik R, Bashan N (2001) Oxidative stress impairs insulin but not platelet-derived growth factor signaling in 3T3-L1 adipocytes. Biochem J 355:757-763
11. Maritim AA, Sanders RA, Watkins JB III (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24-38
12. Haber CA, Lam TKT, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG (2004) N-Acetylcysteine (NAC) and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab (in press)
13. Dröge W (2002) Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37:1333-1345
14. Franceschini G, Werba JP, Safa O, Gikalov I, Sirtori CR (1993) Dose-related increase of HDL-cholesterol levels afterN-acetylcysteine in man. Pharmacol Res 2:213-218
15. Vita J, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF Jr (1998)L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 101:1408-1414
16. Andrews NP, Prasad A, Quyyumi AA (2001)N-Acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 37:117-123
17. Prasad A, Andrews NP, Padder FA, Husain M, Quyyumi AA (1999) Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. J Am Coll Cardiol 34:507-514
18. De Mattia G, Bravi MC, Laurenti O, Cassone-Faldetta M, Proietti A, De Luca O, Armiento A, Ferri C (1998) Reduction of oxidative stress by oralN-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive patients with non-insulin-dependent diabetes. Diabetologia 41:1392-1396
19. Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-529
20. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Müller-Wieland D, Kahn CR (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125
21. Blüher M, Kahn BB, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572-574
22. Partridge L, Gems D (2002) Mechanisms of ageing: public or private? Nat Rev Genet 3:165-175
23. Longo VD, Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299:1342-1346
24. Stöckler-Ipsiroglu S (1997) Creatine deficiency syndromes: a new perspective on metabolic disorders and a diagnostic challenge. J Pediatr 131:510-511
25. Ferrante RJ, Andreassen, OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Daddurah-Daouk R, Hersch SM, Beal MF (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 20:4389-4397
26. Stöckler S, Holzbach U, Hanefeld F, Marquardt I, Helms G, Requart M, Hänicke W, Frahm J (1994) Creatine deficiency in the brain: a new treatable inborn error of metabolism. Pediatr Res 36:409-413
27. Balson PD, Soderlund K, Sjodin B, Ekblom B (1995) Skeletal muscle metabolism during short-duration high intensity exercise: influence of creatine supplementation. Acta Physiol Scand 154:303-310
28. Hespel P, Op't Eijnde B, Van Leemputte M, Ursø B, Greenhaff PL, Labarque V, Dymarkowski S, Van Hecke P, Richter EA (2001) Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol (Lond) 536:625-633
29. Ziegenfuss TN, Rogers M, Lowery L, Mullins N, Mendel R, Antonio J, Lemon P (2002) Effect of creatine loading on anaerobic performance and skeletal muscle volume in NCAA division I athletes. Nutrition 18:398-402
30. Huso ME, Hampl JS, Johnston CS, Swan PD (2002) Creatine supplementation influences substrate utilization at rest. J Appl Physiol 93:2018-2022
31. Horwitz S, Irvine S (2001) Update on American death, disease and exercise. Nat Med 7:878
32. Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the environment: where do we go from here? Science 299:853-855
33. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
35. Kinscherf R, Hack V, Fischbach T, Friedmann B, Weiss C, Edler L, Bärtsch P, Dröge W (1996) Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect ofN-acetylcysteine. J Mol Med 74:393-400
36. Schmid E, El Benna J, Galter D, Klein G, Dröge W (1998) Redox priming of the insulin receptor beta-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 12:863-870
37. Hack V, Breitkreutz R, Kinscherf R, Röhrer H, Bärtsch P, Taut F, Benner A, Dröge, W (1998) The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 92:59-67
38. Gruppuso PA, Boylan JM, Levine BA, Ellis L (1992) Insulin receptor tyrosine kinase domain auto-dephosphorylation. Biochem Biophys Res Commun 189:1457-1463
39. Al-Hasani H, Paßlack W, Klein HW (1994) Phosphoryl exchange is involved in the mechanism of the insulin receptor kinase. FEBS Lett 349:17-22
40. Wei L, Hubbard SR, Hendrickson WA, Ellis L (1995) Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J Biol Chem 270:8122-8130
41. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S (2003) A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348:2082-2090
42. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L (2003) A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 348:2074-2081